Business Segments — Income tax expense (benefit)
Roivant Sciences Business Segments — Income tax expense (benefit) increased by 321.5% to $98.35M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 99.4%, from $49.32M to $98.35M. Over 2 years (FY 2023 to FY 2025), Business Segments — Income tax expense (benefit) shows an upward trend with a 149.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase in tax expense reduces the segment's net contribution, while a tax benefit increases it, often reflecting tax credits or prior-year adjustments.
Detailed definition
This represents the portion of the total income tax expense or benefit specifically allocated to a distinct reportable b...
Peer comparison
Comparable to segment-level tax provisions reported by diversified life sciences or conglomerate companies.
roiv_segment_reportable_segment_income_tax_expense_benefitHistorical Data
| Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.38M | $5.38M | $5.38M | $5.38M | $11.96M | $12.46M | -$25.57M | $49.32M | $4.65M | $7.00M | $23.33M | $98.35M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +122.5% | +4.1% | -305.2% | +292.9% | -90.6% | +50.5% | +233.6% | +321.5% |
| YoY Change | — | — | — | — | +122.5% | +131.7% | -575.6% | +817.5% | -61.1% | -43.9% | +191.3% | +99.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's business segments — income tax expense (benefit)?
- Roivant Sciences (ROIV) reported business segments — income tax expense (benefit) of $98.35M in Q1 2026.
- How has Roivant Sciences's business segments — income tax expense (benefit) changed year-over-year?
- Roivant Sciences's business segments — income tax expense (benefit) increased by 99.4% year-over-year, from $49.32M to $98.35M.
- What is the long-term trend for Roivant Sciences's business segments — income tax expense (benefit)?
- Over 2 years (2023 to 2025), Roivant Sciences's business segments — income tax expense (benefit) has grown at a 149.0% compound annual growth rate (CAGR), from $21.50M to $133.33M.
- What does business segments — income tax expense (benefit) mean?
- The amount of income tax expense or benefit attributed to a specific business segment.